COVAX Advance Market Commitment for COVID-19 vaccines

This project aims to strengthen COVID-19 response and recovery in the Advance Market Commitment 92 (AMC-92) eligible low-and lower-middle-income economies. It reduces COVID-19 related mortality and morbidity particularly amongst vulnerable and priority-use populations through increased access to vaccines. Project activities include: (1) supporting the COVAX Advance Market Commitment in the procurement of COVID-19 vaccines for the AMC 92 eligible economies; and (2) supporting the Pandemic Vaccine Pool in the procurement of vaccines for surges or future pandemic threats vaccine delivery activities and ancillary costs for donated vaccine doses. This represents additional funds provided to the project in response to the COVID-19 pandemic. The description and expected results are the same.

The expected outcomes of this project include: (1) increase access to vaccines for all AMC 92 economies focusing on primary series and boosters as necessary to advance toward national targets for high-priority populations including healthcare workers older adults and the most vulnerable; and (2) increase the number of vaccines provided to the AMC 92 eligible economies.